Turkey's pharma company Gen Ilac jumps after Q1 results

Gen Ilac ve Saglik Urunleri Sanayi Ticaret

11/05/2026 09:02

** Shares in Turkey's Gen Ilac GENIL.IS rise more than 8% after the Turkish pharmaceutical company posted its Q1 results with improved profitability

** It reported on Friday after market close Q1 revenues rising 31% to 6.6 bln lira

** Borekrage Pusula Yatirim views the company's Q1 financials positively, highlighting EBITDA margin of nearly 20%, up 1017 basis points

** The stock is the second best performer on Istanbul's main BIST 100 index .XU100, which is down 0.1%

** Today's spike narrows the group's year-to-date losses to 24%

 (Reporting by Mirac Eren Dereli)

 ((miraceren.dereli@thomsonreuters.com))